Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: amiodarone attending: chief complaint: recent vfib arrest major surgical or invasive procedure: redo sternotomy, avr(21mm porcine)cabgx2(svg>ramus>om), iabp placement history of present illness: 77 yo m s/p mi x 2 and cabg x 4 in . did well until when he had a vf arrest and had cardiac cath with lcx and rca stents at . he was also found to have + mr and was referred for surgery.he wears an external defib life vest. past medical history: chronic systolic heart failure, cad s/p cabg x4 95, mi , 95, mr, b/l varicosities, htn, niddm, bph, hyperchol, afib, copd, cri, external defibrillator, b/l hernia repairs social history: retired engineer denies tobacco, etoh lives with wife family history: nc physical exam: hr 72 rr 18 bp 142/78 elderly m in nad well healed median sternotomy lungs ctab heart irregular rhythm, +murmur abdomen benign extrem warm, no edema, 2+ pp 71" 66.6 kg pertinent results: 06:45am blood wbc-10.3 rbc-3.37* hgb-9.7* hct-29.5* mcv-88 mch-28.9 mchc-32.9 rdw-16.2* plt ct-234 05:55am blood pt-14.1* inr(pt)-1.2* 06:45am blood glucose-147* urean-32* creat-0.9 na-133 k-4.8 cl-94* hco3-27 angap-17 radiology report chest (portable ap) study date of 2:56 pm , fa6a sched chest (portable ap) clip # reason: ptx s/p ct removal medical condition: 77 year old man s/p cabg reason for this examination: ptx s/p ct removal final report clinical history: 77-year-old male status post cabg. evaluate for pneumothorax status post chest tube removal. ap chest radiograph compared to at 10:32 a.m. shows removal of a left apical chest tube with subsequent small apical pneumothorax. the remainder of the exam is unchanged. the heart size remains moderately enlarged. post surgical changes related to a median sternotomy and cabg are redemonstrated. no consolidation is identified. small bilateral pleural effusions persist. the study and the report were reviewed by the staff radiologist. echocardiography report , portable tte (complete) done at 3:05:36 pm final referring physician information , w. , status: inpatient dob: age (years): 77 m hgt (in): 70 bp (mm hg): 110/49 wgt (lb): 171 hr (bpm): 110 bsa (m2): 1.95 m2 indication: s/p cabg, avr icd-9 codes: v42.2, 414.8, 424.0 test information date/time: at 15:05 interpret md: , md test type: portable tte (complete) son: f. , rdcs doppler: full doppler and color doppler test location: west sicu/ctic/vicu contrast: none tech quality: suboptimal tape #: 2008w032-1:15 machine: vivid echocardiographic measurements results measurements normal range left atrium - long axis dimension: *4.5 cm <= 4.0 cm left ventricle - septal wall thickness: 1.1 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: *1.2 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: *5.9 cm <= 5.6 cm left ventricle - systolic dimension: 5.1 cm left ventricle - fractional shortening: *0.14 >= 0.29 left ventricle - ejection fraction: 20% to 25% >= 55% aorta - sinus level: 3.0 cm <= 3.6 cm aortic valve - peak velocity: *2.1 m/sec <= 2.0 m/sec aortic valve - peak gradient: 18 mm hg < 20 mm hg aortic valve - mean gradient: 10 mm hg mitral valve - e wave: 1.1 m/sec mitral valve - e wave deceleration time: *138 ms 140-250 ms tr gradient (+ ra = pasp): *29 mm hg <= 25 mm hg findings left atrium: mild la enlargement. right atrium/interatrial septum: ra not well visualized. left ventricle: mild symmetric lvh. mildly dilated lv cavity. severe regional lv systolic dysfunction. no lv mass/thrombus. no resting lvot gradient. right ventricle: normal rv chamber size and free wall motion. aorta: normal aortic diameter at the sinus level. aortic valve: bioprosthetic aortic valve prosthesis (avr). avr well seated, normal leaflet/disc motion and transvalvular gradients. mitral valve: moderately thickened mitral valve leaflets. no mvp. mild mitral annular calcification. mild thickening of mitral valve chordae. moderate to severe (3+) mr. lv inflow pattern c/w restrictive filling abnormality, with elevated la pressure. tricuspid valve: normal tricuspid valve leaflets. mild to moderate +] tr. mild pa systolic hypertension. pulmonic valve/pulmonary artery: normal pulmonic valve leaflet. no ps. physiologic pr. pericardium: no pericardial effusion. regional left ventricular wall motion: n = normal, h = hypokinetic, a = akinetic, d = dyskinetic conclusions the left atrium is mildly dilated. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity is mildly dilated. there is severe regional left ventricular systolic dysfunction with anterior, anteroseptal and apical akinesis. there is moderate hypokinesis of the remaining segments (lvef = 20-25%). right ventricular chamber size and free wall motion are normal. a bioprosthetic aortic valve prosthesis is present. the aortic valve prosthesis appears well seated, with normal leaflet motion and transvalvular gradients. no aortic regurgitation is seen. the mitral valve leaflets are moderately thickened. there is no mitral valve prolapse. moderate to severe (3+) mitral regurgitation is seen. the left ventricular inflow pattern suggests a restrictive filling abnormality, with elevated left atrial pressure. there is mild pulmonary artery systolic hypertension. there is no pericardial effusion. impression: dilated left ventricle with severe regional dysfunction, c/w multivessel cad. normally-functioning aortic valve bioprosthesis. moderate to severe mitral regurgitation. mild pulmonary hypertension. brief hospital course: he was admitted to cardiac surgery preoperatively for iv heparin and preoperative testing. he was taken to the operating room on where he underwent redo sternotomy, avr and cabg x 2 and iabp placement, please see operative note for details.it was determined that his as was more severe than anticipated, with some mr still present. he was transferred to the icu in stable condition on epinephrine and levophed. chest tube was placed postoperatively for pneumothorax. iabp was dc'd and he was extubated on pod #1. he was seen by electrophysiology for icd consideration but will continue to wear his life vest for 3 months postop. he was transferred to the floor on pod #3. mediastinal tubes removed and left pleural tube remained. pacing wires removed without incident. coumadin restarted for chronic a fib. left chest tube removed with residual small left apical pneumothorax. he was ready for discharge home on pod #8. coumadin to be followed by coumadin clinic as prior to surgery. medications on admission: plavix 75, lisinopril 10, lopressor er 100, metformin 1000", zetia 10, lipitor 80, flomax 0.4, asa 162, coumadin mwf 5, tthss 7.5 discharge medications: 1. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day) for 2 weeks. disp:*60 tablet(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 5. ezetimibe 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. tramadol 50 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. disp:*40 tablet(s)* refills:*0* 8. tamsulosin 0.4 mg capsule, sust. release 24 hr sig: one (1) capsule, sust. release 24 hr po hs (at bedtime). disp:*30 capsule, sust. release 24 hr(s)* refills:*2* 9. metformin 1,000 mg tablet sig: one (1) tablet po twice a day. disp:*60 tablet(s)* refills:*0* 10. toprol xl 50 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. disp:*45 tablet sustained release 24 hr(s)* refills:*0* 11. lasix 20 mg tablet sig: one (1) tablet po twice a day for 2 weeks. disp:*28 tablet(s)* refills:*0* 12. warfarin 5 mg tablet sig: one (1) tablet po once (once) for 1 days: 5 mg mwf, 7.5 mg tthssu as prior to surgery. check inr with results to anticoag management service. disp:*60 tablet(s)* refills:*0* discharge disposition: home with service facility: homecare discharge diagnosis: as s/p avr/cabg chronic systolic heart failure cad s/p cabg x4 95, mi , 95, mr, b/l varicosities, htn, niddm, bph, hyperchol, afib, copd, cri, external defibrillator, b/l hernia repairs discharge condition: stable. discharge instructions: call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week. shower, no baths, no lotions, creams or powders to incisions. no lifting more than 10 pounds in 10 weeks. no driving until follow up with surgeon. continue wearing life vest as prior to surgery. followup instructions: dr. 2 weeks dr. 4 weeks dr. /dr. in 3months - life vest until f/u visit echocardiogram prior to office visit with dr coumadin per coumadin clinic procedure: extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries diagnostic ultrasound of heart open and other replacement of aortic valve with tissue graft implant of pulsation balloon diagnoses: coronary atherosclerosis of native coronary artery congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation chronic kidney disease, unspecified iatrogenic pneumothorax mitral valve insufficiency and aortic valve stenosis acute on chronic systolic heart failure 

Answer: The patient is high likely exposed to